(Q45422947)

English

Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

0 references

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Min Fang

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Hong Cheng

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Zhongping Dai

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Zimei Bu

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

25 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

345

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

231-243

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Viral mechanisms of immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Receptors for gamma-interferon encoded by poxviruses: implications for the unknown origin of vaccinia virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

An antigenic difference between intracellular and extracellular rabbitpox virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Mechanisms of recovery from a generalized viral infection: mousepox. I. The effects of anti-thymocyte serum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Mechanisms of recovery from a generalized viral infection: mousepox. 3. Regression infectious foci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Restricted replication of ectromelia virus in cell culture correlates with mutations in virus-encoded host range gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Monkeypox in the Western hemisphere

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Smallpox vaccination: a review, part II. Adverse events

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Neutralizing and protective antibodies directed against vaccinia virus envelope antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

The complete DNA sequence of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

The looming threat of bioterrorism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Cross priming or direct priming: is that really the question?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Extracellular release of enveloped vaccinia virus from mouse nasal epithelial cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

The mechanism of alpha-helix formation by peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Human monkeypox and smallpox viruses: genomic comparison.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Analysis of the monkeypox virus genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

The formation and function of extracellular enveloped vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

Role of cell-associated enveloped vaccinia virus in cell-to-cell spread

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.056

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2005.09.056

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45422947&oldid=2076922365"